APOFERRITIN: PROTEIN NANOCARRIER FOR TARGETED DELIVERY
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F15%3A10297997" target="_blank" >RIV/00216208:11310/15:10297997 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/15:10297997 RIV/00064203:_____/15:10297997
Result on the web
<a href="http://iapc-obp.com/assets/files/883189NBDD.pdf" target="_blank" >http://iapc-obp.com/assets/files/883189NBDD.pdf</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
APOFERRITIN: PROTEIN NANOCARRIER FOR TARGETED DELIVERY
Original language description
The apoferritin protein nanocage is a very suitable molecule for use as a drug delivery vehicle. Its properties, such as size, excellent biocompatibility, easy modification and simple encapsulation protocol based on structural changes in different pH, present a large advantage when compared to the other nanocarriers. It contains multiple channels in its structure, employable for small nanoparticle synthesis. Due to the encapsulation procedure, a wide variety of different molecules can be encapsulated within its cavity. It can therefore be used for simple chemotherapy, but also the combination of therapy with diagnostics, chemotherapy and photodynamic therapy, gene therapy or hyperthermia therapy. It can be used in not only the treatment of cancer but also other diseases, including bacterial infections. The size of apoferritin is suitable for passive targeting to tumours and its surface can be modified with a variety of targeting moieties for specific use. Due to all these advantages, a
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA14-18344S" target="_blank" >GA14-18344S: Development of nanoparticle-based cytostatics and enzymes for enhanced chemotherapy of human neuroblastomas and study of mechanisms of their action</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Nano Based Drug Delliivery
ISBN
978-953-56942-2-9
Number of pages of the result
22
Pages from-to
217-238
Number of pages of the book
604
Publisher name
IAPC Publishing
Place of publication
Záhřeb
UT code for WoS chapter
—